Semaglutide Raw Powder

Semaglutide Raw Powder - Pharmaceutical Grade API from Avans NutriHealth

Avans NutriHealth Co., Ltd. supplies pharmaceutical-grade Semaglutide Raw Powder (CAS: 910463-68-2) manufactured through rigorous quality control systems. Our lyophilized API features ≥98% purity verified by RP-HPLC, with net peptide content (NPC) typically ranging between 80-90% of total powder weight. This acylated GLP-1 receptor agonist demonstrates an extended half-life of approximately 165 hours, addressing critical stability challenges in peptide therapeutics.

We manufacture our product to international pharmacopeial standards, with bacterial endotoxins kept below 10 EU/mg and TFA content controlled to less than 1%. We provide consistent and quality raw materials for pharmaceutical compounding and research applications backed with full COA documentation and certifications such as ISO, HACCP and FSSC22000 with complete technical support.

What Makes Our Semaglutide Raw Powder Different?

The product is the Active Pharmaceutical Ingredient in bulk before final formulation. Unlike pre-filled pens, this lyophilised intermediate provides pharmaceutical makers full formulation flexibility.

Molecular engineering of this peptide circumvents the inherent instability of GLP-1. An aminoisobutyric acid change at position 8 inhibits enzymatic breakdown by DPP-4. The strong albumin binding is provided by the C-18 fatty diacid chain connected at the 26-position.

Such adjustments considerably increase the residence time of the plasma. consistent potency and less reliance on the cold chain for storage for compounding pharmacies and procurement teams.

Product Specifications

Applications Across Pharmaceutical Development

Your research and manufacturing teams can utilize this API across multiple development pathways. The raw powder format offers maximum formulation flexibility.

Pharmaceutical compounding facilities incorporate it into customized injectable formulations. Research institutions conduct pharmacokinetic studies and mechanism investigations. Contract manufacturers develop novel delivery systems addressing patient compliance challenges.

The extended half-life of approximately 165 hours supports once-weekly dosing regimens. This represents a significant advantage over shorter-acting GLP-1 analogs requiring daily administration.

For health care product development and pharmaceutical applications, this raw material provides the foundation for innovative therapeutic solutions.

Technical Formulation Considerations

Your formulation team has to understand the distinction between purity and peptide content. These parameters affect both the computation of the dose and the effectiveness of the finished product.

Purity vs. Peptide Content: HPLC purity (e.g. 99%) is the ratio of the target peptide sequence to peptide impurities. The peptide content is the net weight of peptide, less water and counter-ions.

High quality raw powder generally has a total weight peptide content of 80-90%. This affects how you calculate active ingredient loading in final formulations.

Counter-Ion Selection: Counter-ion is acetate in pharmaceutical-grade material or ion exchange for removal of TFA. The high TFA level is a cytotoxicity problem and not suited for in vivo applications.

Oral Bioavailability: Active component is raw powder. Complex formulation with permeability enhancers is needed for oral delivery. Direct oral administration leads in almost nil absorption due to gastric enzyme processing.

Stability and Handling Best Practices

Proper handling keeps peptide integrity from our facilities to your lab. Knowing stability parameters saves expensive material loss.

The Semaglutide Raw Powder is stable in the lyophilised state for a limited period at room temperatures. But best practices in the business call for cold-chain shipment with ice packs or dry ice.

This avoids thermal degradation during transportation. Receipt: Store immediately at -20°C or below for extended shelf life.

Reconstitution demands a deft touch.Allow vials to come to room temperature before to addition of buffer solution. Do not shake, swirl gently. Mechanical stress might denature the fragile peptide structure.

GLP-1 peptides aggregate readily. These techniques address this widespread problem and allow you to get the biological activity you want.

Quality Control That Meets International Standards

Pharmaceutical grade peptide procurement is validated to a high standard. Your quality assurance team has to have verified data at each level.

Our comprehensive testing includes:

HPLC Purity Analysis: Detailed chromatograms differentiate the primary peak from synthesis byproducts including des-Gly impurities and oxidised species. This important factor maintains uniformity from batch to batch.

Mass Spectrometry Confirmation: ESI-MS confirmation of exact molecular weight of 4113.58 Da eliminates truncation errors often seen with peptide synthesis.

Net Peptide Content Measurement: NPC considers water, acetates and counterions, unlike basic purity measures. We maintain NPC at ≥80% as per our standard criteria for correct dose calculation.

Endotoxin Testing: LAL tests measure endotoxin levels below 10 EU/mg, a requirement for injectable-grade safety and to avoid pyrogenic responses.

Residual Solvent Analysis: Water content less than 8.0% by Karl Fischer Titration. Acetonitrile and TFA residues are within ICH guidelines

A complete Certificate of Analysis for these parameters is provided with each batch.

FAQ

Q: What is the difference between Peptide Content and Purity?

A: Purity (e.g., 99%) refers to the ratio of the target peptide sequence to impurities measured by HPLC. Peptide Content indicates the net weight of peptide minus water and counter-ions. High-quality raw powder typically contains 80-90% net peptide content of total powder weight.

Q: Does your raw powder use Acetate or TFA as the counter-ion?

A: Our pharmaceutical-grade product utilizes Acetate or has undergone ion exchange to remove Trifluoroacetic acid (TFA). High TFA content is cytotoxic and unsuitable for in vivo applications.

Q: How should I handle reconstitution to avoid aggregation?

A: Aggregation is common with GLP-1 peptides. Allow the vial to reach room temperature before adding buffer. Swirl gently rather than shaking, as mechanical shear stress can denature the peptide structure.

Q: What stability can I expect during shipping?

A: In lyophilized form, the peptide remains stable at ambient temperatures for up to 2 weeks. We ship with ice packs or dry ice following industry standards to prevent thermal degradation and ensure integrity upon arrival.

Q: Can this powder be used directly for oral tablets?

A: The raw powder is the active ingredient, but oral bioavailability requires complex formulation with permeation enhancers. Using raw powder alone orally results in near-zero absorption due to gastric enzyme digestion.

Partner with Avans NutriHealth

Ready to secure a reliable supply of pharmaceutical-grade peptide raw materials with Semaglutide Raw Powder? Contact us today at Lillian@avansnutri.com to discuss your specific requirements and receive detailed product documentation.